Ikena Oncology, Inc.

The momentum for this stock is not very good. Ikena Oncology, Inc. is not a good growth stock. Ikena Oncology, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Ikena Oncology, Inc..
Log in to see more information.

News

Q3 2024 Earnings Estimate for Ikena Oncology, Inc. (NASDAQ:IKNA) Issued By HC Wainwright
Q3 2024 Earnings Estimate for Ikena Oncology, Inc. (NASDAQ:IKNA) Issued By HC Wainwright

Zolmax Ikena Oncology, Inc. (NASDAQ:IKNA - Free Report) - Analysts at HC Wainwright upped their Q3 2024 earnings per share (EPS) estimates for shares of Ikena Oncology in a note issued to investors on...\n more…

Ikena Oncology, Inc. to Post Q3 2024 Earnings of ($0.26) Per Share, HC Wainwright Forecasts (NASDAQ:IKNA)
Ikena Oncology, Inc. to Post Q3 2024 Earnings of ($0.26) Per Share, HC Wainwright Forecasts (NASDAQ:IKNA)

Ticker Report Ikena Oncology, Inc. (NASDAQ:IKNA - Free Report) - Stock analysts at HC Wainwright boosted their Q3 2024 EPS estimates for shares of Ikena Oncology in a report released on Monday, August 12th. HC...\n more…

Ikena Oncology (NASDAQ:IKNA) Receives Buy Rating from HC Wainwright
Ikena Oncology (NASDAQ:IKNA) Receives Buy Rating from HC Wainwright

Ticker Report Ikena Oncology (NASDAQ:IKNA - Get Free Report)s stock had its "buy" rating restated by research analysts at HC Wainwright in a research note issued to investors on Monday, Benzinga reports...\n more…

IKNA Stock Earnings: Ikena Oncology Beats EPS for Q2 2024
IKNA Stock Earnings: Ikena Oncology Beats EPS for Q2 2024

InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nIKNA stock results show that Ikena Oncology beat analyst estimates for earnings per share the second quarter of 2024.\nThe post IKNA...\n more…

Ikena Oncology Reports Second Quarter 2024 Financial Results
Ikena Oncology Reports Second Quarter 2024 Financial Results

Globe Newswire Strong financial position with $145 million in cash and investments at close of second quarterBOSTON, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc. (Nasdaq: IKNA, Ikena, Company ) today...\n more…

Acadian Asset Management LLC Raises Position in Ikena Oncology, Inc. (NASDAQ:IKNA)
Acadian Asset Management LLC Raises Position in Ikena Oncology, Inc. (NASDAQ:IKNA)

Zolmax Acadian Asset Management LLC lifted its stake in Ikena Oncology, Inc. (NASDAQ:IKNA - Free Report) by 1,201.8% in the 1st quarter, according to its most recent Form 13F filing with the Securities and...\n more…